Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 22% ± 7% | |
lung | 10 studies | 28% ± 11% | |
kidney | 6 studies | 22% ± 5% | |
intestine | 6 studies | 24% ± 11% | |
pancreas | 4 studies | 33% ± 17% | |
eye | 4 studies | 27% ± 12% | |
uterus | 4 studies | 26% ± 12% | |
bone marrow | 3 studies | 17% ± 1% | |
liver | 3 studies | 37% ± 27% | |
breast | 3 studies | 18% ± 2% | |
brain | 3 studies | 24% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6236.61 | 1445 / 1445 | 100% | 122.91 | 183 / 183 |
skin | 100% | 6830.69 | 1809 / 1809 | 100% | 195.19 | 472 / 472 |
thymus | 100% | 4813.87 | 653 / 653 | 100% | 192.18 | 605 / 605 |
uterus | 100% | 5299.46 | 170 / 170 | 100% | 238.50 | 459 / 459 |
brain | 100% | 6054.40 | 2640 / 2642 | 100% | 205.91 | 705 / 705 |
kidney | 100% | 4154.52 | 89 / 89 | 100% | 137.92 | 900 / 901 |
ovary | 100% | 3602.66 | 180 / 180 | 100% | 124.88 | 429 / 430 |
adrenal gland | 100% | 5261.74 | 258 / 258 | 100% | 124.22 | 229 / 230 |
liver | 100% | 3959.36 | 225 / 226 | 100% | 170.66 | 406 / 406 |
breast | 100% | 5099.30 | 459 / 459 | 99% | 179.17 | 1112 / 1118 |
intestine | 100% | 5671.33 | 966 / 966 | 99% | 162.47 | 524 / 527 |
pancreas | 99% | 2785.01 | 326 / 328 | 100% | 160.57 | 178 / 178 |
stomach | 100% | 4462.36 | 359 / 359 | 99% | 141.01 | 284 / 286 |
lung | 100% | 5144.76 | 576 / 578 | 99% | 172.37 | 1149 / 1155 |
prostate | 100% | 4923.40 | 244 / 245 | 99% | 166.30 | 499 / 502 |
bladder | 100% | 5260.14 | 21 / 21 | 99% | 186.89 | 497 / 504 |
adipose | 100% | 5281.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6619.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 173.06 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 304.05 | 29 / 29 |
muscle | 100% | 10946.18 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4284.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 282.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 85.42 | 1 / 1 |
heart | 99% | 5972.16 | 855 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 2689.80 | 773 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901800 | Biological process | positive regulation of proteasomal protein catabolic process |
GO_0043921 | Biological process | modulation by host of viral transcription |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000502 | Cellular component | proteasome complex |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0000932 | Cellular component | P-body |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0008540 | Cellular component | proteasome regulatory particle, base subcomplex |
GO_0022624 | Cellular component | proteasome accessory complex |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0036402 | Molecular function | proteasome-activating activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | PSMC3 |
Protein name | 26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1) Proteasome 26S subunit, ATPase 3 |
Synonyms | TBP1 |
Description | FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC3 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. . |
Accessions | ENST00000531051.6 ENST00000602866.5 E9PMD8 E9PN50 ENST00000530651.5 ENST00000298852.8 ENST00000530887.5 ENST00000530912.5 P17980 ENST00000527906.5 E9PS45 ENST00000619920.4 E9PKD5 E9PMW0 ENST00000526993.1 E9PLG2 E9PM69 ENST00000524447.6 R4GNH3 |